. Effect of C. sinica or α-viniferin on cell viability. (A) B16-F0 cells were incubated with C. sinica or α-viniferin for 72 h in the presence of α-MSH, and reacted with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 50 µg/mL) for another 3 h. 
GSK-3α/β inhibitors (6BIO, SB216763), p38 MAPK inhibitors (SB202190, SB203580), dual inhibitors of PP1 and PP2A (okadaic acid, calyculin A) or PP2B inhibitors (cyclosporin A, deltamethrin) for 2 h and stimulated with α-MSH for 1 h or db-cAMP for 20 min in the presence of α-viniferin or each of the inhibitors. Cell extracts were subjected to Western blot (WB) analysis with anti-p-CREB or anti-CREB antibody.
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Okadaic acid (10 nM) Table S1 . Melanin index or lightening index of individual patients.
Clinical investigation was designed as a randomized, double-blind, vehicle-controlled, split-face trial. Twenty-three patients (Korean women, W-1 to W-23) aged 24-55 years, who had melasma and freckles on both sides of the face, were topically applied with C. sinica cream on one half of the face (n = 23) and vehicle cream on the other half (n = 23) in a twicedaily regimen for consecutive 8 wk. Melanin index on the face was measured at baseline (0 time), 4 wk, 6 wk or 8 wk using mexameter (A), and lightening index using chromameter (B).
Data were analyzed with ANOVA followed by the Student's t-test. 
